SGS has acquired aster.cephac, a full service provider of early clinical pharmacology trials and bioanalytical drug development services headquartered in Paris, France. With its 82-bed, newly refurbished state-of-the-art clinic, aster.cephac is one of the largest intensive care facilities in the world with access to a large volunteer base in Europe. Also, the company has recently invested in a modern and GMP-conforming pharmacy. Its facilities are in full compliance with the recent EU Directive....